Switzerland's Tecan prelim FY sales fall 1.6% in local currencies

Tecan AG

09/01/2026 05:43

Overview

Swiss lab automation firm's prelim FY 2025 sales fell 1.6% in local currencies

Company's order entry grew 3.8% in local currencies for FY 2025

Tecan confirmed 2025 profitability guidance and medium-term outlook

Outlook

Tecan expects gradual recovery of end markets in 2026

Company reaffirms 2025 adjusted EBITDA margin guidance

Tecan anticipates mid- to high-single-digit organic growth rates medium-term

Result Drivers

ORDER ENTRY GROWTH - Tecan reported an 8.6% increase in order entry in local currencies for the second half of 2025, indicating strong demand

PARTNERING BUSINESS GROWTH - Partnering Business sales increased by 3.3% in local currencies in the second half of 2025

LIFE SCIENCES DECLINE - Life Sciences Business sales declined by 3.2% in local currencies in the second half of 2025

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Prelim FY Sales
CHF 882.50 mln
CHF 913.40 mln (8 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the office equipment peer group is "buy."

Wall Street's median 12-month price target for Tecan Group AG is CHF165.00, about 17.7% above its January 8 closing price of CHF140.20

The stock recently traded at 26 times the next 12-month earnings vs. a P/E of 23 three months ago

Press Release: ID:nGNE40ct9n

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)